Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 39, Over the last 2 decades, the development of bispecific antibodies (BsAbs) has revolutionized cancer treat-ment. 1 Developed to address drug resistance and to improve treatment safety and efficacy, bispecific antibodies have 2 distinct binding domains that can bind to 2 antigens or epitopes simultaneously. Although BsAbs are a promising new therapeutic approach, especially for hematologic malignancies in

Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 39, Colorectal cancer ranks as the third most common cancer globally and is the second leading cause of cancer-related deaths in the US. 1 More than half of these cases are associated with modifiable risk factors, such as smoking, obesity, high alcohol consumption, and physical inactivity. Over the past few decades, the death rate from colorectal cancer has been declining due to better health behaviors,

Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 39, Access to nutrition services for patients with cancer who are at risk for treatment- and disease-related issues such as malnutrition, dehydration, nausea, and diarrhea is a key component of the care pathway. Even with specialists available, the biggest challenge can be to successfully connect patients to these services. This connection point is improved by reducing barriers and optimizing processes—and